Christine Carbone
Structural Biology Scientist Relay Therapeutics
Deirdre Costello is an accomplished professional in structural biology, currently serving as the Associate Director at Genesis Therapeutics since March 2025. Prior experience includes the role of Principal Scientist at Treeline Biosciences and multiple positions at Eli Lilly and Company, where Deirdre advanced from Research Scientist to Senior Research Scientist. Academic credentials include a PhD and MS in Chemical and Biomolecular Engineering from Cornell University, complemented by a BS in Chemical Engineering from University College Dublin. Deirdre’s doctoral research focused on the fusion kinetics of influenza, contributing to the development of anti-fusogenic therapeutics. Additional experience includes a postdoctoral position at Harvard Medical School and instructional roles fostering engineering education for youth.
Seminars
- Comparing access, cost, and timelines for large pharma versus biotechs, and when outsourcing or academic partnerships make more sense
- Addressing challenges around data volume, selection, and cloud storage
- How data processing, classification, and refinement workflows impact turnaround time and confidence in results
- Current constraints including size limits, flexibility, heterogeneity, and challenges with smaller molecules or weak interactions
- Emerging hardware, sample preparation strategies, and computational advances aimed at improving resolution, throughput, and applicability
